June 23rd 2025
As its director, Manusis outlines the facility’s role in delivering advanced, personalized solutions to improve vision and patient experience.
New advancements in IOL technology is exciting for presbyopia treatment
May 11th 2022Catching up after ASCRS 2022, Ora's Caitlin Black, senior director and therapeutic area head of medical devices, talks about the next generation of ophthalmic device therapies and diagnostics, clinical trial updates and new innovations that are most exciting for presbyopia treatment.
Watch
CSF-1 Phase 2B clinical trials for presbyopia met primary and secondary endpoints
April 25th 2022In a presentation at the American Society of Cataract and Refractive Surgery’s 2022 annual meeting, Marjan Farid, MD, ABO, and Preeya K. Gupta, MD, offered details of clinical trials for CSF-1 ophthalmic solution, a presbyopia eye drop candidate. Results showed that nearly half of the participants treated with CSF-1 achieved a 3-line or more increase in the distance-corrected near visual acuity an hour after drop instillation on day 15.
Read More
Alcon introduces VR surgical training technology
April 12th 2022This advancement reinforces Alcon’s commitment to surgeon training and education, as part of the Alcon Experience Academy. The new device will be introduced at the upcoming ASCRS meeting and surgeons will be able to experience the new technology firsthand.
Read More